Digest Network Come funziona
Network
/
Società
Qu
Non verificato

Quiver Bioscience

Di cosa scriviamo

BiotecnologiaFarmaceuticaIndustriaSaluteScienza

5 comunicati stampa

Guarda tutti i comunicati
01/07/2025
Scienza
Farmaceutica
Tecnica
Biotecnologia
Medicina - Varie
Salute
Quiver Bioscience Secures Non-Dilutive Funding to Enhance CNS Genetic Medicine Drug Discovery Platform Capabilities and Advance Powerful AI/ML-Based In Vitro / In Silico Predictor of CNS Drug Safety
Fonte
Quiver Bioscience
Emittente
Business Wire
1.00
0
16/06/2025
Scienza
Tecnica
Tecnologie Varie
Biotecnologia
Farmaceutica
Salute
Mercato del lavoro
Industria
Quiver Bioscience Appoints Graham Dempsey, PhD as Chief Executive Officer to Lead Scaling of AI-Driven CNS Platform and Advance Lead Program into the Clinic
Fonte
Quiver Bioscience
Emittente
Business Wire
1.00
0
15/05/2025
Mercato del lavoro
Industria
Scienza
Biotecnologia
Farmaceutica
Salute
Quiver Bioscience and QurAlis Announce Research Collaboration to Advance Novel Therapeutic Approach for Fragile X Syndrome
Fonte
Quiver Bioscience
Emittente
Business Wire
1.00
0
19/03/2025
Mercato del lavoro
Industria
Scienza
Biotecnologia
Sanità
Salute
Quiver Bioscience Announces Collaboration with the Dup15q Alliance to Advance Antisense Oligonucleotide Therapeutic Program
Fonte
Quiver Bioscience
Emittente
Business Wire
1.00
0
21/11/2024
Salute
Biotecnologia
Scienza
Farmaceutica
Industria
Quiver Bioscience Announces Publication in Nature Communications Biology Detailing Application of the Quiver Genomic Positioning System (Brain GPS) to Therapeutic Discovery in Fragile X Syndrome using Human Models and Machine Learning Analysis
Fonte
Quiver Bioscience
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0